OTCBB:CVSI
CV Sciences, Inc. Stock News
$0.0580
+0.0020 (+3.57%)
At Close: Jun 25, 2024
CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript
02:10pm, Tuesday, 14'th May 2024
CV Sciences, Inc. (OTCQB:CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants
CV Sciences, Inc. Reports First Quarter 2024 Financial Results
09:00am, Tuesday, 14'th May 2024
SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
07:35pm, Monday, 13'th May 2024
SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
09:00am, Wednesday, 08'th May 2024
SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript
11:42am, Thursday, 28'th Mar 2024
CV Sciences, Inc. (CVSI) Q4 2023 Earnings Call Transcript
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
09:00am, Thursday, 28'th Mar 2024
SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
08:00am, Tuesday, 26'th Mar 2024
Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN DIEGO , March 26, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
09:00am, Thursday, 21'st Mar 2024
SAN DIEGO , March 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in nutraceuticals an
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
08:00am, Tuesday, 12'th Dec 2023
SAN DIEGO , Dec. 12, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV Sciences, Inc. (CVSI) Q3 2023 Earnings Call Transcript
02:07pm, Tuesday, 14'th Nov 2023
CV Sciences, Inc. (OTCQB:CVSI) Q3 2023 Earnings Conference Call November 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg G
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
09:00am, Tuesday, 14'th Nov 2023
SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
09:00am, Thursday, 09'th Nov 2023
SAN DIEGO , Nov. 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot
CV Sciences, Inc. Launches Reserve Sleep Gummies
08:00am, Tuesday, 05'th Sep 2023
Premium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "
CV Sciences, Inc. (CVSI) Q2 2023 Earnings Call Transcript
01:30pm, Monday, 14'th Aug 2023
CV Sciences, Inc. (OTCQB:CVSI) Q2 2023 Earnings Conference Call August 14, 2023 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participa
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
09:00am, Monday, 14'th Aug 2023
SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
